• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Network Wireless Solutions (NWS) Appoints Michael Millegan to Board of Directors

    9/14/21 2:00:00 PM ET
    $AXS
    $COR
    $POR
    $WTT
    Property-Casualty Insurers
    Finance
    Other Pharmaceuticals
    Health Care
    Get the next $AXS alert in real time by email

    The communications industry veteran brings years of experience to NWS

    Network Wireless Solutions, LLC ("NWS"), a rapidly growing solutions and logistics provider to carriers and telecommunications contractors, announced today the appointment of Michael Millegan to its board. NWS is a portfolio company of Grain Management, LLC ("Grain"), a leading Washington, D.C.-based investment firm focused on the global communications sector.

    Mr. Millegan is a seasoned technology executive with several years of experience leading company strategy, including sales, marketing, supply chain operations, cell site build-out, and engineering. Currently, Mr. Millegan serves as an independent board director for AXIS Capital Holdings Limited (NYSE:AXS), Core Site Realty Corporation (NYSE:COR), Portland General Electric Company (NYSE:POR), and Wireless Telecom Group (NYSE:WTT). Previously, Mr. Millegan held executive leadership and management positions within Verizon as President of Verizon Global Wholesale, where he was responsible for US$11 billion in sales revenue, 13,000 employees and US$1 billion in annual capital spending.

    "We are thrilled to appoint a seasoned industry professional of Mr. Millegan's caliber," said NWS President John Hamilton. "Having recently partnered with Grain Management, and with Mr. Millegan joining to lend his deep, results-oriented industry expertise, NWS is in a prime position to maximize our market opportunity."

    "Mr. Millegan's stellar career in the wireless space speaks for itself," said David Grain, founder and CEO of Grain. "Michael's expertise and successes in the industry are well established, and I am confident his leadership and strategic abilities will be a vital ingredient for NWS's growth."

    About NWS

    Since 2012, NWS has provided a wide array of mission-critical services to the wireless telecommunications industry. The company has established itself as a critical partner to carriers, project managers, and general contractors through its expertise, quality of service, and ability to develop and deliver custom cabling solutions and equipment exactly when needed. By combining extensive industry knowledge, a disciplined focus on customer service, and high-quality materials, NWS is a proven partner to keeping cell sites running smoothly.

    About Grain Management

    Grain Management, LLC is a leading private investment firm that focuses on broadband infrastructure and technology companies that connect the world to the information economy. Founded in 2007, Grain invests exclusively in the global telecommunications sector, employing a rigorous, data-based process buoyed by deep industry expertise to identify investment opportunities in key areas of telecommunications infrastructure, including fiber networks, wireless spectrum, and cell towers. For more information visit www.graingp.com.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20210914006019/en/

    Get the next $AXS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AXS
    $COR
    $POR
    $WTT

    CompanyDatePrice TargetRatingAnalyst
    Portland General Electric Co
    $POR
    5/5/2025$50.00Neutral → Buy
    UBS
    Portland General Electric Co
    $POR
    4/10/2025$44.00Overweight → Neutral
    Analyst
    Portland General Electric Co
    $POR
    2/18/2025$42.00Buy → Neutral
    Ladenburg Thalmann
    Axis Capital Holdings Limited
    $AXS
    1/13/2025$93.00Market Perform
    BMO Capital Markets
    Portland General Electric Co
    $POR
    1/3/2025$52.00 → $47.00Buy → Neutral
    UBS
    Axis Capital Holdings Limited
    $AXS
    12/11/2024$78.00 → $89.00Underweight → Equal Weight
    Wells Fargo
    Cencora Inc.
    $COR
    12/4/2024$280.00Outperform
    Mizuho
    Axis Capital Holdings Limited
    $AXS
    10/4/2024$118.00Buy
    TD Cowen
    More analyst ratings

    $AXS
    $COR
    $POR
    $WTT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Nally Dennis M was granted 121 shares, increasing direct ownership by 0.92% to 13,251 units (SEC Form 4)

      4 - Cencora, Inc. (0001140859) (Issuer)

      5/5/25 4:07:07 PM ET
      $COR
      Other Pharmaceuticals
      Health Care
    • Director Baumann Werner was granted 125 shares, increasing direct ownership by 5% to 2,896 units (SEC Form 4)

      4 - Cencora, Inc. (0001140859) (Issuer)

      5/5/25 4:05:32 PM ET
      $COR
      Other Pharmaceuticals
      Health Care
    • Director Tyler Lauren M was granted 104 shares, increasing direct ownership by 4% to 2,875 units (SEC Form 4)

      4 - Cencora, Inc. (0001140859) (Issuer)

      5/5/25 4:03:54 PM ET
      $COR
      Other Pharmaceuticals
      Health Care

    $AXS
    $COR
    $POR
    $WTT
    Financials

    Live finance-specific insights

    See more
    • Cencora Reports Fiscal 2025 Second Quarter Results

      Revenue of $75.5 billion for the Second Quarter, a 10.3 percent Increase Year-Over-Year Second Quarter GAAP Diluted EPS of $3.68 and Adjusted Diluted EPS of $4.42 Adjusted Diluted EPS Guidance Range Raised to $15.70 to $15.95 for Fiscal 2025 Cencora, Inc. (NYSE:COR) reported that in its fiscal year 2025 second quarter ended March 31, 2025, revenue increased 10.3 percent year-over-year to $75.5 billion. On the basis of U.S. generally accepted accounting principles (GAAP), diluted earnings per share (EPS) was $3.68 for the second quarter of fiscal 2025 compared to $2.09 in the prior year second quarter. Adjusted diluted EPS, which is a non-GAAP financial measure that excludes items described

      5/7/25 6:30:00 AM ET
      $COR
      Other Pharmaceuticals
      Health Care
    • AXIS Capital Reports First Quarter Net Income Available to Common Shareholders of $187 Million, or $2.26 Per Diluted Common Share and Operating Income of $261 Million, or $3.17 Per Diluted Common Share

      For the first quarter of 2025, the Company reports: Annualized return on average common equity ("ROACE") of 13.7% and annualized operating ROACE of 19.2% Combined ratio of 90.2% Book value per diluted common share of $66.48, an increase of $9.35, or 16.4%, over the past twelve months AXIS Capital Holdings Limited ("AXIS Capital" or "AXIS" or "the Company") (NYSE:AXS) today announced financial results for the first quarter ended March 31, 2025. Commenting on the first quarter 2025 financial results, Vince Tizzio, President and CEO of AXIS Capital said: "AXIS delivered another strong quarter of consistent, profitable performance as we continued to lean into our specialty underwritin

      4/30/25 4:15:00 PM ET
      $AXS
      Property-Casualty Insurers
      Finance
    • Portland General Electric Announces First Quarter 2025 Results

      First quarter financial results reflect strong energy demand from high-tech and data centers, which drove total quarter-over-quarter load growth of 4.6% and 16.4% industrial load growthReaffirming 2025 adjusted earnings guidance of $3.13 to $3.33 per diluted sharePORTLAND, Ore., April 25, 2025 /PRNewswire/ -- Portland General Electric Company (NYSE:POR) today reported net income based on generally accepted accounting principles (GAAP) of $100 million, or $0.91 per diluted share, for the first quarter of 2025. This compares with GAAP net income of $109 million, or $1.08 per diluted share, for the first quarter of 2024. After adjusting for the impact of the January 2024 storm, first quarter 20

      4/25/25 5:00:00 AM ET
      $POR
      Electric Utilities: Central
      Utilities

    $AXS
    $COR
    $POR
    $WTT
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Mental Health Awareness Month: AXIS/Harris Poll Survey Finds Nearly 9 in 10 (88%) Insurance Employees Acknowledge Widespread Stress and Anxiety in the Industry

      Timed to the start of Mental Health Awareness Month, AXIS Capital Holdings Limited ("AXIS Capital" or the "Company") (NYSE:AXS) partnered with The Harris Poll to survey the state of mental health within the insurance profession. The research findings revealed a number of trends pointing to widespread and rising stress and anxiety; a desire for better mental health support; and a belief that insurance trails other industries in prioritizing mental health initiatives. The survey, conducted mid-April 2025, was fielded during a time when insurance professionals are facing tremendous change in the risk environment brought on by factors such as economic volatility, rising geopolitical tensions,

      5/8/25 10:30:00 AM ET
      $AXS
      Property-Casualty Insurers
      Finance
    • Cencora Reports Fiscal 2025 Second Quarter Results

      Revenue of $75.5 billion for the Second Quarter, a 10.3 percent Increase Year-Over-Year Second Quarter GAAP Diluted EPS of $3.68 and Adjusted Diluted EPS of $4.42 Adjusted Diluted EPS Guidance Range Raised to $15.70 to $15.95 for Fiscal 2025 Cencora, Inc. (NYSE:COR) reported that in its fiscal year 2025 second quarter ended March 31, 2025, revenue increased 10.3 percent year-over-year to $75.5 billion. On the basis of U.S. generally accepted accounting principles (GAAP), diluted earnings per share (EPS) was $3.68 for the second quarter of fiscal 2025 compared to $2.09 in the prior year second quarter. Adjusted diluted EPS, which is a non-GAAP financial measure that excludes items described

      5/7/25 6:30:00 AM ET
      $COR
      Other Pharmaceuticals
      Health Care
    • AXIS Capital Reports First Quarter Net Income Available to Common Shareholders of $187 Million, or $2.26 Per Diluted Common Share and Operating Income of $261 Million, or $3.17 Per Diluted Common Share

      For the first quarter of 2025, the Company reports: Annualized return on average common equity ("ROACE") of 13.7% and annualized operating ROACE of 19.2% Combined ratio of 90.2% Book value per diluted common share of $66.48, an increase of $9.35, or 16.4%, over the past twelve months AXIS Capital Holdings Limited ("AXIS Capital" or "AXIS" or "the Company") (NYSE:AXS) today announced financial results for the first quarter ended March 31, 2025. Commenting on the first quarter 2025 financial results, Vince Tizzio, President and CEO of AXIS Capital said: "AXIS delivered another strong quarter of consistent, profitable performance as we continued to lean into our specialty underwritin

      4/30/25 4:15:00 PM ET
      $AXS
      Property-Casualty Insurers
      Finance

    $AXS
    $COR
    $POR
    $WTT
    Leadership Updates

    Live Leadership Updates

    See more
    • Sara Farrup Becomes AXIS Head of Global Markets

      AXIS Capital Holdings Limited ("AXIS Capital" or "AXIS" or the "Company") (NYSE:AXS) today announced Sara Farrup (nee Mitchell) has assumed the role of Head of Global Markets as part of a planned leadership transition, first announced in September 2024. Ms. Farrup, who reports to AXIS President and CEO Vince Tizzio and is part of the Company's Executive Committee, succeeds longtime Head of Global Markets Mark Gregory, who will continue to serve as a strategic advisor to the Company through March. Ms. Farrup is based in the Company's London office. "I am proud to join AXIS as Head of Global Markets at this exciting point in the Company's journey," commented Ms. Farrup. "I feel privileged t

      1/6/25 8:45:00 AM ET
      $AXS
      Property-Casualty Insurers
      Finance
    • Cencora Expands Enterprise Leadership Team with Two Senior Appointments

      Francois Mandeville Named Executive Vice President, Strategy and M&A Pawan Verma Appointed Executive Vice President, Chief Data and Information Officer Cencora, Inc. (NYSE:COR) today announced the appointment of Francois Mandeville as Executive Vice President, Strategy and M&A, and Pawan Verma as Executive Vice President, Chief Data and Information Officer. Both leaders will join Cencora's enterprise leadership team, bringing their extensive experience and expertise to help advance the company's pharmaceutical-centric strategy and drive growth for Cencora and its customers. "We're thrilled to welcome Francois and Pawan to Cencora's leadership team," said Bob Mauch, President and Chief Ex

      11/4/24 8:30:00 AM ET
      $COR
      Other Pharmaceuticals
      Health Care
    • AXIS Appoints Pranav Shroff to Lead Life Sciences in North America

      AXIS Capital Holdings Limited ("AXIS Capital" or "AXIS" or the "Company") (NYSE:AXS) today announced that Pranav Shroff has joined the Company as Head of Life Sciences in North America. Mr. Shroff will lead the development of a suite of specialty coverages in support of the life sciences industry, with an initial focus on Products Liability, Professional Liability, and Clinical Trials Liability. His responsibilities include executing on the underwriting strategy, cultivating relationships with our distribution partners in this specialty segment, and building a team to support this initiative. Bringing extensive underwriting experience and knowledge of life sciences, Mr. Shroff joins AXIS

      9/9/24 9:15:00 AM ET
      $AXS
      Property-Casualty Insurers
      Finance

    $AXS
    $COR
    $POR
    $WTT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Portland Gen Elec upgraded by UBS with a new price target

      UBS upgraded Portland Gen Elec from Neutral to Buy and set a new price target of $50.00

      5/5/25 8:34:55 AM ET
      $POR
      Electric Utilities: Central
      Utilities
    • Portland Gen Elec downgraded by Analyst with a new price target

      Analyst downgraded Portland Gen Elec from Overweight to Neutral and set a new price target of $44.00

      4/10/25 8:50:33 AM ET
      $POR
      Electric Utilities: Central
      Utilities
    • Portland Gen Elec downgraded by Ladenburg Thalmann with a new price target

      Ladenburg Thalmann downgraded Portland Gen Elec from Buy to Neutral and set a new price target of $42.00

      2/18/25 7:12:13 AM ET
      $POR
      Electric Utilities: Central
      Utilities

    $AXS
    $COR
    $POR
    $WTT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • EVP, COO Felton Benjamin bought $522 worth of shares (11 units at $47.49), increasing direct ownership by 0.04% to 30,153 units (SEC Form 4)

      4 - PORTLAND GENERAL ELECTRIC CO /OR/ (0000784977) (Issuer)

      9/13/24 1:55:36 PM ET
      $POR
      Electric Utilities: Central
      Utilities
    • Galanski Stanley A bought $142,860 worth of shares (2,000 units at $71.43), increasing direct ownership by 20% to 11,763 units (SEC Form 4)

      4 - AXIS CAPITAL HOLDINGS LTD (0001214816) (Issuer)

      5/30/24 5:13:32 PM ET
      $AXS
      Property-Casualty Insurers
      Finance
    • Durcan Dermot Mark bought $109,290 worth of shares (500 units at $218.58), increasing direct ownership by 2% to 21,876 units (SEC Form 4)

      4 - Cencora, Inc. (0001140859) (Issuer)

      5/29/24 4:02:27 PM ET
      $COR
      Other Pharmaceuticals
      Health Care

    $AXS
    $COR
    $POR
    $WTT
    SEC Filings

    See more
    • SEC Form 10-Q filed by Cencora Inc.

      10-Q - Cencora, Inc. (0001140859) (Filer)

      5/7/25 1:48:31 PM ET
      $COR
      Other Pharmaceuticals
      Health Care
    • Cencora Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Cencora, Inc. (0001140859) (Filer)

      5/7/25 6:36:20 AM ET
      $COR
      Other Pharmaceuticals
      Health Care
    • SEC Form DEFA14A filed by Axis Capital Holdings Limited

      DEFA14A - AXIS CAPITAL HOLDINGS LTD (0001214816) (Filer)

      5/5/25 8:11:16 AM ET
      $AXS
      Property-Casualty Insurers
      Finance

    $AXS
    $COR
    $POR
    $WTT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Axis Capital Holdings Limited

      SC 13G/A - AXIS CAPITAL HOLDINGS LTD (0001214816) (Subject)

      11/14/24 1:28:31 PM ET
      $AXS
      Property-Casualty Insurers
      Finance
    • Amendment: SEC Form SC 13G/A filed by Cencora Inc.

      SC 13G/A - Cencora, Inc. (0001140859) (Subject)

      11/14/24 1:22:34 PM ET
      $COR
      Other Pharmaceuticals
      Health Care
    • Amendment: SEC Form SC 13D/A filed by Cencora Inc.

      SC 13D/A - Cencora, Inc. (0001140859) (Subject)

      8/5/24 6:43:49 PM ET
      $COR
      Other Pharmaceuticals
      Health Care